Metoprolol tartrate and Cirrhosis alcoholic - a phase IV clinical study of FDA data

Summary:

Cirrhosis alcoholic is found among people who take Metoprolol tartrate, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Metoprolol tartrate and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 71,517 people who have side effects when taking Metoprolol tartrate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jun, 10, 2022

71,517 people reported to have side effects when taking Metoprolol tartrate.
Among them, 10 people (0.01%) have Cirrhosis alcoholic.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 76,613 Metoprolol tartrate users for its effectiveness, alternative drugs and more.

What is Cirrhosis alcoholic?

Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 355 drugs and 152 conditions by eHealthMe.

Number of Metoprolol tartrate and Cirrhosis alcoholic reports submitted per year:

Could Metoprolol tartrate cause Cirrhosis alcoholic?

Gender of people who have Cirrhosis alcoholic when taking Metoprolol tartrate *:

female: 10 %
male: 90 %

Age of people who have Cirrhosis alcoholic when taking Metoprolol tartrate *:

Common drugs people take besides Metoprolol tartrate *:

Common side effects people have besides Cirrhosis alcoholic *:

Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 6 people, 60.00%
Renal Failure Acute (rapid kidney dysfunction): 6 people, 60.00%
Hyperkalemia (damage to or disease of the kidney): 5 people, 50.00%
Cardiac Failure: 5 people, 50.00%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 5 people, 50.00%
Prostatic Specific Antigen Increased: 5 people, 50.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 5 people, 50.00%
Oedema Peripheral (superficial swelling): 5 people, 50.00%
Colitis (inflammation of colon): 5 people, 50.00%
Peritonitis Bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial): 5 people, 50.00%

Common conditions people have *:

Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 10.00%
Pain: 1 person, 10.00%
Neuralgia (pain in one or more nerves): 1 person, 10.00%
Nerve Injury: 1 person, 10.00%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 10.00%
Nausea (feeling of having an urge to vomit): 1 person, 10.00%
Joint Pain: 1 person, 10.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 10.00%
Depression: 1 person, 10.00%
Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and have Cirrhosis alcoholic?

Check whether Cirrhosis alcoholic is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Metoprolol tartrate:

Metoprolol tartrate (76,613 reports)

Cirrhosis alcoholic treatments and more:

Cirrhosis alcoholic (749 reports)

COVID vaccines that are related to Cirrhosis alcoholic:

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate (the active ingredients of Metoprolol tartrate) and Metoprolol tartrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.